Why attend East Tech West?


East Tech West is an invite-only retreat taking place on the 17th – 18th November 2020, at the LN Garden Nansha which is rapidly developing into a global hub of tech innovation.

Each year the event unites senior business and technology leaders from around the globe, as we discuss the latest innovations and implementations of technology. CNBC’s award winning anchors and reporters will host panels, fire-side chats, and workshops that explore the drivers of this transformation and how to stay ahead.

This year we bring you the same event, with new opportunities designed to help businesses navigate the rapidly evolving tech landscape, and how succeed in the new world. With the increasing need to respond and transform, we will hear from pioneers of the digital economy, rising stars and tech giants sharing their immediate response, while chartering a course towards a better future.


Xiaodong Chen

Mr. Xiaodong Chen has been the Chief Executive Officer of Intime Retail (Group) Company Limited, since January 6, 2009. Mr. Chen has been the President of Intime Retail (Group) Company Limited since January 2009. He is responsible for the overall management of Intime Retail (Group) Company Limited. He has been an Executive Director at Intime Retail (Group) Company Limited since June 7, 2011. He served as Chief Operating Officer of Intime Retail (Group) Company Limited from July 2007 to January 2009 and served as its Vice President since February 2007. Mr. Chen has extensive experience in the department store industry, financial management and capital markets. He served as Chief Financial Officer of Intime Retail (Group) Company Limited since February 2007.

Mr. Chen served as Vice President and Chief Financial Officer of Intime Retail (Group) Company Limited since November 2006. He has more than ten years of experience in financial management and capital markets. He served as President of Science City Development Public Co., Ltd. from October 2004 to November 2008. He served as an Assistant General Manager of the Investment Management Department of China Everbright Holdings Company Limited from May 2001 to August 2004. He served as Vice Chairman of Science City Development Public Co., Ltd. from October 2004 to November 2008. Mr. Chen serves as a Director of Wenling Intime Properties Limited. He served as a Director of Baida Group Company Limited from May 2008 to May 2011. Mr. Chen has a Bachelor degree in Economics from Zhongshan University and a Master degree in Business Administration from Murdoch University, Australia.

Ginni Rometty

Virginia M. (Ginni) Rometty is the former Executive Chairman of IBM. She was previously Chairman, President and Chief Executive Officer.

Ginni became Chairman, President and Chief Executive Officer of IBM in 2012. During her tenure she made bold changes to reposition IBM for the future, investing in high value segments of the IT market and optimizing the company’s portfolio. Under Ginni’s leadership, IBM built out key capabilities in hybrid cloud, security, quantum computing, industry expertise, and data and AI, both organically and through acquisition. IBM acquired 64 companies during Ginni’s tenure as CEO, including Red Hat, the largest acquisition in the company’s history. She reinvented more than 50 percent of IBM’s portfolio, built a $21 billion hybrid cloud business and established IBM’s leadership in AI, quantum computing and blockchain, while divesting nearly $10 billion in annual revenue to focus the portfolio on IBM’s high-value, integrated offerings.

Ginni also established IBM as the model of responsible stewardship in the digital age. She was the industry’s leading voice on technology ethics and data stewardship, working relentlessly to safely usher new technologies into society. She enabled people of diverse backgrounds and education levels to participate in the digital economy by building talent, skills and opportunity for disadvantaged populations. Under her leadership, IBM created thousands of New Collar jobs and championed the reinvention of education around the world, including the explosive growth of the six-year Pathways in Technology Early College High Schools, or P‑TECHs, which are helping prepare the workforce of the future, serving hundreds of thousands of students in over 200 schools and 24 countries. She also helped to redefine the purpose of the corporation through her work with the Business Roundtable, expanding corporate commitments to include a wide range of stakeholders, from customers to communities.

IBM also achieved record results in diversity and inclusion under Ginni’s leadership. This included extending parental leave and making it easier for women to return to the workforce through a ‘returnships’ program with hands-on work experience in emerging technologies. This pioneering work was recognized in 2018 by the prestigious Catalyst Award for advancing diversity and women’s initiatives. IBM is the only tech company to have earned this recognition in the past 20 years and the only company ever to be honored four times.

Beginning her career with IBM in 1981, Ginni held a series of leadership positions across the company and led the successful integration of PricewaterhouseCoopers Consulting, creating a global team of more than 100,000 business consultants and services experts.

Ginni has a Bachelor of Science degree with high honors in computer science and electrical engineering from Northwestern University, where she later was awarded an honorary degree. She also has honorary degrees from Rensselaer Polytechnic Institute and North Carolina State University.

She serves on the Council on Foreign Relations, the board of trustees of Northwestern University, where she is a Vice Chair, and the boards of overseers and managers of Memorial Sloan-Kettering Cancer Center. She is co-chair of the Aspen Institute’s Cyber Group, a member of the advisory board of Tsinghua University School of Economics and Management, and a member of the Singapore Economic Development Board International Advisory Council.

Victor AI

Victor is the founder and CEO of Terminus Group, a leading AI smart service provider, focused on shaping the next generation technology with AIoT (Artificial Intelligence & the Internet of Things). In July this year, Terminus Group was officially announced as the Premier Partner for the Expo 2020 Dubai, with the company planning to set up its first overseas headquarters in Dubai. AI CITY solutions have emerged to address the ever-growing challenges of the urbanization processes and constantly prove to be the future driving force of the global economies. Over the years, Terminus Group has managed to successfully secure its leading position in the industry, not only by being at the forefront of emerging technologies but also by deploying its proven solutions in different cities around the globe. With the ambition of becoming the undisputed leader of the AI CITY industry, Terminus Group is transforming the cities of Chongqing, Beijing, Nanjing into what is known as shining examples of AI Cities of tomorrow. And the list is enlarging as more cities swarm into, with the expectation to be a leading AI CITY in the future. Furthermore, Terminus Group, being the core strategic technology platform of China Everbright Limited (CEL), has recently launched the 'CEL AI New Economy Fund' with total funding of $1.45 billion together with CEL, aiming to accelerate the global deployment of Terminus Group's AI CITY Network. By connecting finance and tech industry, the project will surely facilitate the construction of the new intelligent infrastructure and lay the foundation for the new model of AI CITY.

Charles Li

Charles Li is the Chief Executive of HKEX with over 20 years of experience in the financial services sector. He has orchestrated some of the most significant strategic initiatives in HKEX’s history, including the acquisition of the London Metal Exchange in 2012 and the launch of OTC Clear in 2013. He was also the architect of the groundbreaking Shanghai-Hong Kong Stock Connect cross-border trading scheme in 2014, which was expanded to include Shenzhen-Hong Kong Stock Connect in 2016 and Bond Connect in 2017. Li was also successful in leading the biggest reforms to Hong Kong’s Listing Rules in a quarter century, opening the door to pre-revenue biotech companies and new economy companies with non-standard share structures for the first time.

Li has also been a member of the Chinese People’s Political Consultative Conference since 2018 and is the co-chair of the World Economic Forum’s Annual Meeting of New Champions in 2019.

CG Lai

CG Lai is CEO of BNP Paribas (China) Ltd. and is responsible for overseeing the bank's strategic growth and overall business development in this rapidly growing and vital market.

CG joined BNP Paribas in 1996. Before being appointed CEO for BNP Paribas China, most recently CG was Deputy CEO of BNP Paribas China, leading China Capital Market platform and Head of Global Markets for Greater China.

CG brings to the table impressive breadth of banking experience and his deep insights into the ever-changing China marketing gained over 30 years. He held various senior positions in BNP Paribas, including Head of Fixed Income for Greater China, and Head of Corporate Group Asia (Ex-Japan), Fixed income for the bank. Prior to joining BNP Paribas, he worked for Chase Manhattan Bank and American Express Bank.

CG received his Master in Business Administration from the University of Washington.

Xiaochun, Zhang

Mr. Zhang Xiaochun was graduated from Dongbei University of Finance & Economics. Since 2000, he has dedicated to the Internet industry. In 2010, he assisted Mr. Liao Jieyuan in founding the Guahao.com (WeDoctor Group) as a co-founder. In his career, Mr.Zhang has been the CEO of Galaxy Internet TV and the general manager of New Media Company of China National Radio.

Dr. Chun Yuan Chiang

Dr Chiang is a global health practitioner and technology entrepreneur. He graduated in medicine from Hong Kong University after a background in electronic engineering in The Hong Kong Polytechnic University. Influenced by his heritage of a long established and respected medical family in China, he strives to combine both Western and Traditional approaches in medicine in the best interest of the patients.

He is the founder of IHDpay Group. He is appointed as the Chief Advisor of the technical committee of AFS-IT which is in cooperation with FATF-APG, an inter-governmental body to set standards and promote effective implementation of legal, regulatory and operational measures for combating threats to the integrity of the international financial system.

Ning Wang

Lijun Xin

Lijun Xin is full of curiosity and a quick learner. After graduating from Shanghai Jiaotong University in 1995, Xin worked as a teacher for four years and then entered the IT industry for seven years. After that, he started his own business for eight years until he joined JD.com in 2012. At that time, JD.com only had its retail business, and the burden of developing a third-party platform business fell to Xin.
Eight years later, he successfully developed the business logic of JD.com’s third-party platform business, and constantly expanded its business categories, from apparel to cars, real estate, art, health, and so on. Xin has served as the person in charge of these businesses. In July 2019, he officially became CEO of JD Health.

Dr. Wanli Min

Founder and CEO of North Summit Capital and QuadTalent Technology, Dr. Min is a leading expert in industrial intelligence and business innovations powered by data technology and mathematics. He pioneers a 'technology + capital' strategy to accelerate digital transformation in various industries ranging from e-commerce to manufacturing and smart city.

Dr. Min received a Ph.D. in statistics from The University of Chicago and B.S from the University of Science & Technology of China. His research area includes probability, stochastic process, time series analysis, machine learning, smart traffic and signal processing. He served as a researcher at IBM T.J. Watson Research Center, IBM Singapore, and Google before joining Alibaba in 2013. Later as Chief Machine Intelligence Scientist for Alibaba Cloud, Dr. Min took charge R&D in the data intelligence solutions. In 2017, Dr. Min was named by Forbes as a leading technologist driving China's AI revolution and also appointed to the advisory committee of the next-generation AI strategy under China's Ministry of Science and Technology.

Mike Wells

Mike Wells has been Group Chief Executive of the international financial services group Prudential plc since June 2015.

Prudential’s purpose is to help remove uncertainty from life’s big events, providing customers with the freedom to face the future with greater confidence. Founded in London in 1848 and based in the UK, Prudential provides long-term savings and protection products, retirement income solutions and asset management through its businesses on four continents – Prudential Corporation Asia and Eastspring Investments in Asia,

Jackson National Life Insurance in the US, M&G Prudential in the UK and Europe, and Prudential Africa.

Since becoming Group Chief Executive, Mike has overseen continued growth across Prudential’s key metrics, with the Group delivering record IFRS operating profit of more than £4.2 billion in 2016, and its assets under management reaching £635 billion.

Mike joined Jackson, Prudential’s North American unit, in 1995, and became Jackson’s Chief Operating Officer and Vice-Chairman in 2003. In 2011 he was appointed President and CEO of Jackson and joined the board of Prudential. He has more than three decades’ experience in insurance and retirement services, having started his career at the US brokerage house Dean Witter before becoming a managing director at Smith Barney Shearson.

Mike was born in Ontario, Canada, and earned a Bachelor of Sciences in Economics from San Diego State University.

Wang Huiyao

Dr. Huiyao (Henry) WANG is the Founder and President of Center for China and Globalization (CCG), a leading Chinese non-government think tank that ranked among top 80 think tanks in the World. Dr. Wang is also an adviser to the Chinese government, having been appointed as Counselor for China State Council, China’s Cabinet by Chinese Premier in 2015. Dr. Wang is a thought leader on China and globalization, global governance, global trade and investment, global migration and talent flows, China’s international relations and China-U.S. trade relations.

Dr. Yan Li

Li Yan, CEO of Niu Technologies in China. Before joining Niu Technologies, he was a principal of KKR (Capstone), one of the world largest private equity firm in the U.S., responsible for KKR’s portfolio operation in China. At KKR, he has been actively involved in portfolio companies such as Qingdao Haier Group (listed in China A share), China Modern Dairy (listed in HongKong Stock Exchange), China Cord Blood Corporations (listed in NYSE) and United Envirotech (listed in Singapore Stock Exchange). He was also awarded Operational Excellence Award by Private Equity International in 2012.
Prior to joining KKR Capstone, Dr. Li was with McKinsey & Company, where he advised various companies in telecom, high-tech, industrial goods and retail sectors. He started his career as a senior research engineer at Qualcomm Inc., U.S., where he holds three patents on 3G communications. He holds a B.S. from the University of California at Berkeley and a Ph.D. from Stanford University.

Edward Huaxiang Xu

Mr. Edward Huaxiang Xu has served as Chief Strategy Officer for Ehang Holdings Ltd since July 2019. Prior to joining Ehang, Mr. Xu served as Head of Asia (ex-Japan) Transportation Research at Morgan Stanley Asia Limited.

During his 15-year career as an equity research analyst at Morgan Stanley, he covered China’s aerospace and transportation industries extensively, including airlines, logistics, airports, and railways, among others.

Mr. Xu is a CFA charterholder. He obtained his Bachelor’s degree in English Information Management from Beijing Foreign Studies University in 1998 and his Master’s degree in Business Administration (MBA) from University of Illinois at Urbana-Champaign in 2003.

Jenny Zeng

Jenny Zeng is the Founder & Managing Partner of MSA Capital, a Chinese private equity firm focused on healthcare, tech and consumer internet. With over 18 years extensive industry experience, she has played a key role in most of the Firm’s iconic investments, including Meituan(SEHK:03690), Nio(NYSE:NIO), BGI(SZ:300676), Yidu Cloud and Kanzhun/Boss Zhipin, and T11 fresh Market.

Before founding MSA, Jenny was the first Executive Director of China Venture Capital and Private Equity Association (“CVCA”) since 2002 and has founded Maple Valley Investments in 2004, a boutique financial advisory firm providing a range of corporate advisory and private placement services to blue-chip Chinese clients.

Recently Jenny has been awarded the Top 20 Healthcare Investors (36Kr) in 2020.She also sits on the Board of Directors of China Future Forum and on the Greater China Advisory Board of The Nature Conservancy.

Sizhen Wang

Sizhen Wang is Co-founder & CEO of Genetron Health.

With extensive interdisciplinary entrepreneurial experience and corporate management capabilities, he leads the team in the exploration of cancer genomics, the application of bio-innovative technologies and changes in human health.

- Co-founded Genetron Health in 2013, a leading precision oncology platform company in China. Genetron Health’s service portfolio covers the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The company has since served tens of thousands of cancer patients, the high-risk groups as well as hundreds of research institutes, hospitals and pharmaceutical firms around the world. In June 2020, the company has been listed in Nasdaq with ticker GTH.
- Co-founded iTalkBB in 2004, which business covers millions of users around the world and has grew to become the leading Internet communication brand among Chinese communities in North America and Australia.
- 7 years of working experience in the banking industry for Capital One and GD Capital.
- MBA, HEC Paris School of Management.

Frank Su

Frank has nearly 20 years of experience in the pharmaceutical industry and has taken senior management position for many well-known big pharma such as Johnson & Johnson. He also co-founded Techlink medical, a surgical product company.

Later, Frank joined Shenzhen Share Capital as a partner and founded Redhill Capital. He incubated many well-known medical enterprises including Beijing Genetron Health, Guangzhou Medprin Regenerative Medical., Beijing Hocremed, Juventas Cell Therapy and, etc.

Hongye Wang

Hongye is Partner of Antler China, where he shares the overall responsibility for Antler in China, including investment, capital, operations and strategy.

Hongye was a founding Partner of Tsing Ventures, a well-established early stage venture capital firm based in Beijing with over 2.6 billion RMB AUM and close links with the Tsinghua scientific and alumni network. At Tsing Ventures, Hongye was responsible for investor relations and investment opportunities in the deep-tech, enterprise services, education and entertainment verticals, with successes including Kr Space (first round investor, now a Unicorn company), XFZ (first round, now one of the most famous financial advisors in China), Invis Power (pre-A investor, now the only provider for wireless charging in car in China), PACEE (seed investor, STEM education company, successfully exited at 500% return in two years) among others. Hongye was recognized as a 30-under-30 investor for 2015 and 2017 by XFZ and Most Promising Investor for 2016 by 36Kr among other accolades.

Most recently, Hongye was Senior Director of Investments at Fosun Group, focusing on the TMT sector as well as other businesses such as a C2M company with assets worth >100 billion USD. Hongye began his career in Schneider Electric and Digital China strategy divisions, holds an MBA from the Tsinghua-MIT joint program and has a Bachelor of Engineering Physics from Tsinghua University.

Eric Lin

Eric has been the Head of UBSS Research since 2019. He was previously Head of Asia Transportation Research, leading the team to cover over 50 APAC aviation, shipping and logistics stocks. He has been part of the ranked Transportation and Infrastructure team since joining UBS in 2010.

In the 2018 Institutional Investor and Asiamoney surveys, he was ranked No. 1 Best Analyst for Transportation in Asia. Prior to joining UBS, Eric was a Transport Analyst at HSBC Global Research.

He is a Fellow Chartered Certified Accountant (FCCA), which he earned at PricewaterhouseCoopers. He holds a Bachelor of Arts (Geography) degree from the University of Hong Kong.

Sir Douglas Flint

Sir Douglas’ wide-ranging international and financial experience is an important asset to the business as it delivers against its strategy. His strong track record of board leadership as a chairman helps to facilitate open and constructive boardroom discussion.

Previously, Sir Douglas served as chairman of HSBC Holdings plc from 2010 to 2017. For 15 years prior to this he was HSBC’s group finance director, joining from KPMG where he was a partner. Between 2005 and 2011 he also served as a non-executive director of BP plc.

In other current roles, Sir Douglas is chairman of IP Group plc and serves as HM Treasury's special envoy to China's Belt and Road Initiative. He is also a member of the Monetary Authority of Singapore's international advisory panel, and of the board of the International Chamber of Commerce UK.

Additionally, he is chairman of the Just Finance Foundation, non-executive director of the Centre for Policy Studies, member of the global advisory council of Motive Partners and board member of the Institute of International Finance. He also chairs the Corporate Board of Cancer Research UK and is a trustee of the Royal Marsden Cancer Charity.

He holds a BAcc (Hons) from the University of Glasgow, a PMD from Harvard Business School and is a Member of the Institute of Chartered Accountants of Scotland.

Fiona Frick

Fiona Frick is Chief Executive Officer of Unigestion and has more than 30 years’ experience in the asset management industry.

During more than a decade in this role she has developed a high profile in the international asset management industry and academic circles as a respected speaker on economics, financial markets and the rise of sustainable finance.

Fiona is a frequent commentator on financial markets for CNBC, Bloomberg TV and Sky News and is a regular speaker at events such as the Milken conference, the CFA Institute, Fund Forum, 100 Women in Finance, Bloomberg Invest, IPE and the Robin Hood Investors Conference. She also gives lectures at universities such as IMD Business School, Imperial College London and Oxford around the evolution of asset management and the impact of sustainability.

She serves on the boards of Swiss Sustainable Finance and Sustainable Finance Geneva and is also a member of the EMEA committee of the Standards Board for Alternative Investments. Fiona has been recognised by Financial News on numerous occasions as one of the 100 Most Influential Women in European Finance

Fiona started her career as a fundamental analyst at Unigestion, covering traditional asset classes in the 1990s. During her early career, she worked as an investment manager responsible for high yield and convertible bond funds and in 1995, led the development of the company’s equity activities. As Head of the Equities team, she was responsible for the development of an innovative approach for managing equities based on the Minimum Variance anomaly which was then implemented into the firm’s investment solutions. Fiona was appointed Chief Executive Officer of the Company in January 2011.

Fiona holds a Masters in Business Administration from the Institut Supérieur de Gestion (I.S.G.) in Paris and graduated with a degree in Literature and Philosophy from the University of Dijon. She has also completed a number of executive education programmes at the IMD Business School in Lausanne.

Liu Qiang

Mr. Qiang Liu is Vice President at Shanghai Fosun Pharmaceutical Development Co. Ltd.

Mr. Liu was previously employed as a Member-Management Team by Shanghai Fosun Pharmaceutical.He received his MBA from the Cheung Kong Graduate School of Business.

Mu Chen

Chen Mu is the Chairman of BigOne Lab, Co-editor of Baiguan News, and Director of Canopy. He is also a guest lecturer at the Tsinghua University PBC School of Finance and a specially appointed expert of Beijing City. He graduated from the University of Virginia.

BigOne Lab is dedicated to developing data products for corporate clients and global institutional investors. It has received over 100 million yuan in investments from Shanghai International, ZhenFund, CGC, and S&P. BigOne Lab serves hundreds of global investment institutions, consumer brands, and new economy companies, including Sequoia Capital, JPMorgan Chase, Goldman Sachs, Yum China, L'Oreal Paris, Zippos, Didi, Meituan, Genki Forest, and Luckin Coffee.

Michael Jiang

Michael Jiang currently serves as the Acting CEO of WeWork China. He manages all aspects of WeWork’s operation and business development in Greater China, including Mainland China, Hong Kong and Taiwan.

Michael is an Operating Partner of Trustbridge Partners. Prior to that, Michael was a Senior Vice President of Meituan-Dianping. He played an important role in the integration process after Meituan-Dianping’s merger and acquisition, leading various businesses and corporate functions including new retail and user platforms. Prior to the merger of Meituan and Dianping, Michael served as Vice President of Product & Operations and Chief Strategy Officer at Dianping. Michael had more than 15 years of experience in engineering, product and management at several software and Internet companies including Tencent, Yahoo, and Kana.

Michael holds a Ph.D. degree in Computer Software from Fudan University, an MBA degree from Haas School of Business, University of California Berkeley, and Master's and Bachelor's degrees in Computer Science from Shandong University.

Jianxiong Xiao

Jianxiong Xiao (a.k.a., Professor X) is the Founder and CEO of AutoX, a world-leading company in self-driving car technologies. AutoX's mission is to democratize autonomy and enable autonomous driving to improve everyone's life. Dr. Xiao has over ten years of research and engineering experience in Computer Vision, Autonomous Driving, and Robotics. In particular, he is a pioneer in the fields of 3D Deep Learning, RGB-D Recognition and Mapping, Big Data, Large-scale Crowdsourcing, and Deep Learning for Robotics. Jianxiong received a BEng. and MPhil. in Computer Science from the Hong Kong University of Science and Technology in 2009. He received his Ph.D. from the Computer Science and Artificial Intelligence Laboratory (CSAIL) at the Massachusetts Institute of Technology (MIT) in 2013. And he was an Assistant Professor at Princeton University and the founding director of the Princeton Computer Vision and Robotics Labs from 2013 to 2016. His work has received the Best Student Paper Award at the European Conference on Computer Vision (ECCV) in 2012 and the Google Research Best Papers Award for 2012, and has appeared in the popular press. He was awarded the Google U.S./Canada Fellowship in Computer Vision in 2012, the MIT CSW Best Research Award in 2011, NSF/Intel VEC Research Award in 2016, and two Google Faculty Awards in 2014 and in 2015 respectively. He co-lead the MIT+Princeton joint team to participate in the Amazon Picking Challenge in 2016, and won the 3rd and 4th place worldwide. He was named to be one of the 35 Innovators Under 35 by MIT Technology Review in 2017. More information can be found at: http://www.jianxiongxiao.com.

Chris Chen

Dr. Chris Chen is currently Chief Executive Officer at WuXi Biologics, leading a 1500-member team providing end-to-end biologics services to global partners. At WuXi he has built a world-class open-access integrated mab discovery, development and manufacturing platform serving full spectrum of companies ranging from virtual companies to 12 large pharma. Under his leadership, WuXi has assembled one of the largest biologics development teams with over 700 scientists enabling 40 global INDs in two years. WuXi is also currently building the largest disposable-bioreactor based state-of-the-art commercial manufacturing facility totaling 30,000L bioreactor capacity in the world. He obtained his dual bachelor degrees of chemical engineering and automation at Tsinghua University, Beijing China and his Ph.D. in chemical engineering at the University of Delaware, US. He then gained valuable experience in process development, manufacturing, technology transfer, process validation, quality, and regulatory in the US, where his previous assignments include director and manager positions of bioprocess development, technical service, and pilot plant operations at Lilly and Merck. Dr. Chen later joined Shanghai Celgen Biopharmaceuticals as Chief Operating Officer, successfully developed a high-titer high-quality commercial process for biosimilar Enbrel, and obtained regulatory approval for the program in China in 2011. He chaired multiple conferences in biochemical engineering and mab development in US and China and is frequently invited to speak at multiple conferences. He is also adjunct professor at Shanghai Jiaotong University. Dr Chen is co-author and co-inventor of 40+ publications and patents.

Mark Mobius

In 2018 Mark founded Mobius Capital Partners with his Templeton colleagues Carlos von Hardenberg and Greg Konieczny. The active investment manager focuses on one single and concentrated strategy centred around improving governance standards in emerging market companies. For Mobius Capital Partners Mark continues to trot the globe to meet with management teams all over the world in his quest to discover undervalued companies before others do.

Prof. Wensheng Wei

- Professor at School of Life Sciences, Peking University

- Principal Investigator at Peking University’s Biomedical Frontier Innovation Center (BIOPIC), Beijing Future Genetic Diagnosis Advanced Innovation Center (ICG) and Peking University-Tsinghua Life Sciences Joint Center (CLS), Director of Peking University’s Genome Editing Research Center

- He holds a bachelor's degree in biochemistry from Peking University, a doctorate in genetics from Michigan State University, and completed his postdoctoral research at Stanford University

Jerome Kim

Jerome H. Kim, M.D., is the Director General of the International Vaccine Institute (IVI). He served as the Principal Deputy and Chief of the Laboratory of Molecular Virology and Pathogenesis at MHRP, in addition to being the Project Manager for the HIV Vaccines and Advanced Concepts Evaluation Project Management Offices, U.S. Army Medical Material Development Activity U.S.A., Dr. Kim was a Professor within the Division of Infectious Diseases of the Department of Medicine at the Uniformed Services University of the Health Sciences. From 2004 – 2009 he led the Army’s Phase III HIV vaccine trial (RV144), the first demonstration that an HIV vaccine could protect against infection, as well as subsequent studies that identified laboratory correlates of protection and sequence changes in breakthrough HIV infections after vaccination. Dr. Kim graduated from the Yale University School of Medicine in 1984 and completed his training in Internal Medicine and fellowship in Infectious Diseases at Duke University Medical Center. In 2013 he received the John Maher Award for Research Excellence from the Department of Medicine, Uniformed Services University of the Health Sciences. Throughout his career to date, Dr. Kim has authored over 200 publications.

Carl Wu

Mr. Carl Wu is the Co-Founder and CEO of New Frontier Group. Mr. Wu is a healthcare and internet entrepreneur. He is the Executive Chairman and Co-founder of YD Care (home healthcare service provider), Heal (oncology group in the Greater Bay area), Boxful Technology (the leading on-demand storage service provider in Asia), HelloToby Technology (the leading online service marketplace in Hong Kong) and Precision Medical. Carl is also the Chairman of Care Alliance (the leading post-acute healthcare operator in China), Chairman of the Executive Committee of New Frontier Health / United Family Healthcare (NYSE: NFH).

Prior to founding New Frontier, Mr. Wu was one of the youngest Managing Directors at Blackstone and executed some of Blackstone’s most important investments in China. He was a founding member of Blackstone Asia and was instrumental in establishing Blackstone’s businesses across China. Prior to moving to Hong Kong, Mr. Wu was based in Blackstone’s London office. Before joining Blackstone, he worked in investment banking at UBS in London.

Mr. Wu holds a Bachelor of Science in Economics from the London School of Economics, where he graduated with First Class Honors.

Dong Kexin

Kent Dong is Senior Vice President and Head of Corporate and Media Partnerships, China, at ONE Championship. He has over 20 years of experience spanning sports marketing, IP commercialization, brand management and athlete management. He spent over 10 years in marketing and brand management, with experience at both fortune 500 companies such as Coca-Cola and IBM, and creative agencies including O&M and Publicis. In addition, he has over 10 years of experience in sports marketing and management, holding senior positions at both NBA China and VIVA China Sports. He was the exclusive manager of Lin Dan, two-time Olympic gold medalist and China’s biggest sports star, and was responsible for making Lin Dan China’s most commercially valuable athlete. Kent completed the General Management Program at Harvard Business School and has a BA in Economics from the University of International Business and Economics.


This agenda is subject to change.

8.00 AM


9.30 AM

Welcome and Introduction

John Casey, CNBC International President & Managing Director Max Raven, CNBC International Senior Vice President Dong Ke, Vice Secretary of CPC Nansha District Committee, Mayor of Nansha District, Executive Deputy Director General of the Administrative Committee of Guangzhou Nansha Development Zone (Free Trade Zone) Feng Xingya, General Manager of GAC Group

10.30 AM

Morning Networking Break

10.50 AM

Working Together - Succeeding in the new normal

Chen Xiaodong, VP, Alibaba and CEO, InTime

11.05 AM

GLOBAL VIEWPOINT: Leading through the Pandemic - How has IBM managed its workforce throughout the pandemic

Ginni Rometty, Executive Chairman, IBM

11.15 AM

Global Viewpoint: Adopting a More Digital World for the Future

Charles Li, Executive Director, HKEX

11.30 PM

FIRESIDE CHAT: China's Role in Globalization - The Reset

Xiao Wunan, Executive Vice Chairman, Asia Pacific Exchange and Cooperation Foundation

11.45 PM

Networking Lunch

2.05 PM

Global Investment Outlook Panel Discussion - Opportunities and Recovery Pathways

Hongye Wang, Partner, Antler
Eric Lin, Head of Research, China, UBS Securities Co. Limited

2.20 PM

Global Viewpoints: China and the World

Sir Douglas Flint, Chairman, Standard Life Aberdeen
Fiona Frick, CEO, Unigestion
Mark Mobius, Founder, Mobius Capital partners

2.35 PM

Global Investment Outlook Panel: Empowering Investment with Tech

Mu Chen, CEO and Co-founder, BigONE Lab

2.50 PM

Fireside Chat: China's Post Pandemic Recovery Strategy

CG Lai, CEO, BNP Paribas China

3.00 PM

Global Investment Outlook: Long-term Investment Opportunities in China

Jenny Zeng, Managing Partner, MSA Capital

3.10 PM

FIRESIDE CHAT: Scaling Up - Opportunities for Fintech

Liu Qiang, Vice President, Fosun Technology and Financial Group, Deputy Chairman, Hani Securities

3.25 PM

Sustainable Development of the Digital Economy

Dr Chiang Chun Yuan, Founder and Chairman, Technology Committee, FINDA System and Co-Chair Digital-Health-Global-Initiative, UNSDG
Wang Huiyao, Founder and President, Center for China and Globalization (CCG)

3.45 PM

Fireside Chat: Workspace Post Pandemic - Flexible Office Solutions

Michael Jiang, CEO, WeWork China

5.00 PM

Pre-Gala Networking Drinks

6.30 PM

Gala Dinner

This agenda is subject to change.

7.00 AM


9.15 AM

Welcome and Introduction

9.20 AM

Panel Discussion: Innovative Ways in Tackling Life Threatening Disease

Dr. Wensheng Wei, Founder, EdiGene
Sizhen Wang, Chief Executive Officer, Genetron Health
Frank Su, Chief Executive Officer, TCRcure Biopharma

9.40 AM

Tech Spotlight: The Rise of the Online Doctor

Xiaochun Zhang, Co-founder, Wedoctor Group
Carl Wu, Co-founder and CEO, New Frontier Group

9.55 AM

Global Viewpoints: Health-Tech Pioneers Offering Global Solutions

Chris Chen, CEO, Wuxi Biologics

10.10 AM

Masterclass: Tapping into China's 6 Trillion Yuan Healthcare Market

Lijun Xin, CEO, JD Health

10.30 AM

Morning Networking Break

11.05 AM


Xu Lei, CEO, JD Retail

11.20 AM


David Liu, VP of Strategy, Pinduoduo

11.35 AM

The Future of Health and Wellness - Remarking on the Post Pandemic Wellness Industry

Wang Yang, Founder and CEO, YunMai
Jie Xu, CEO, Good Feeling Holdings

11.55 AM

Global Viewpoints: Promoting Health Inclusion through Digital Technology

Mike Wells, CEO, Prudential PLC

12.05 PM

GLOBAL VIEWPOINT: AI in Health and Wellbeing

Taejong Jay (TJ) Yang, Senior Vice President, Samsung Electronics

12.20 PM

Networking Lunch

2.10 PM

Panel Discussion: Acceleration in Digitalization

Ning Wang, Co-founder and Chief Business Officer, PingPong Payments
Jason Song, Founder & President, PKFARE

2.35 PM

Post Pandemic Fan Experience Revival

Dong Kexin, SVP, One Championship

2.45 PM

Global Viewpoints: Acceleration in Digitalization

Hugh Chow, Chief Executive Officer, ASTRI

2.55 PM


Imran Khan, ex-CSO, Snapchat

3.05 PM

Emerging Trends in Urban Mobility

Edward Xu, CSO, Ehang
Jianxiong Xiao, CEO, Auto X
Yan Li, CEO, NIU Technologies

3.25 PM

A Climate for Change - Rebalancing Supply Chains

Min Wanli, CEO and Founder, North Summit Capital

3.40 PM

Closing Remarks


Discover emerging tech and partnerships shaping the future.


Increase your readiness and succeed in the new world with winning strategies.


Unlock business transformation and kickstart sustainable growth.



What's new for 2020?